BXT (BXT) News
Follow BXT (BXT) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
BioNxt Advances GLP-1 Sublingual Semaglutide ODF Program with Next Stage of Delivery Development Underway
VANCOUVER, BC / / July 6, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:B
EQUITY | Jul 06, 2026, 07:05 AM UTC
L
BNXT: Closes Private Placement
BioNxt announces closing of non-brokered private placement of units
EQUITY | Jun 23, 2026, 09:20 PM UTC